Skip to main content
Erschienen in: Virchows Archiv 4/2017

01.06.2017 | Original Article

B-cell lymphomas with discordance between pathological features and clinical behavior

verfasst von: Laurence de Leval, Christiane Copie-Bergman, Andreas Rosenwald, Lisa Rimsza, Stefania Pittaluga, Bettina Bisig, Stefan Dirnhofer, Fabio Facchetti, Stefano Pileri, Falko Fend, Andrew Wotherspoon

Erschienen in: Virchows Archiv | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

B-cell lymphomas encompass a large number of disease entities clinically ranging from indolent to aggressive. The defining pathological features usually predict clinical course, with small and large B-cell lymphomas correlating to low-grade vs high-grade features, but discordant situations may be encountered. Two sessions of the workshop of the XVIII meeting of the European Association for Haematopathology (EAHP) held in Basel in 2016 addressed this topic. One session illustrated various facets of “aggressiveness” in indolent lymphomas, either peculiar clinical manifestations, cytological variants, or unusual genetic features, as well as several examples of progression or transformation to a more aggressive disease. Another session exemplified large B-cell lymphomas with unexpected indolent behavior including cases arising in well-defined body compartments or in sanctuary sites. This paper describes the features of the cases presented in both groups, highlights the most salient points of discussion raised by the submitters and the panel, and summarizes current knowledge and recommendations relevant to diagnostic pathology practice.
Literatur
4.
Zurück zum Zitat Ladanyi M, Offit K, Parsa NZ, Condon MR, Chekka N, Murphy JP, Filippa DA, Jhanwar SC, Dalla-Favera R, Chaganti RS (1992) Follicular lymphoma with t(8;14)(q24;q32): a distinct clinical and molecular subset of t(8;14)-bearing lymphomas. Blood 79:2124–2130PubMed Ladanyi M, Offit K, Parsa NZ, Condon MR, Chekka N, Murphy JP, Filippa DA, Jhanwar SC, Dalla-Favera R, Chaganti RS (1992) Follicular lymphoma with t(8;14)(q24;q32): a distinct clinical and molecular subset of t(8;14)-bearing lymphomas. Blood 79:2124–2130PubMed
6.
Zurück zum Zitat Wang SA, Wang L, Hochberg EP, Muzikansky A, Harris NL, Hasserjian RP (2005) Low histologic grade follicular lymphoma with high proliferation index: morphologic and clinical features. Am J Surg Pathol 29:1490–1496CrossRefPubMed Wang SA, Wang L, Hochberg EP, Muzikansky A, Harris NL, Hasserjian RP (2005) Low histologic grade follicular lymphoma with high proliferation index: morphologic and clinical features. Am J Surg Pathol 29:1490–1496CrossRefPubMed
7.
Zurück zum Zitat Xerri L, Dirnhofer S, Quintanilla-Martinez L, Sander B, Chan JK, Campo E, Swerdlow SH, Ott G (2016) The heterogeneity of follicular lymphomas: from early development to transformation. Virchows Arch 468:127–139. doi:10.1007/s00428-015-1864-y CrossRefPubMed Xerri L, Dirnhofer S, Quintanilla-Martinez L, Sander B, Chan JK, Campo E, Swerdlow SH, Ott G (2016) The heterogeneity of follicular lymphomas: from early development to transformation. Virchows Arch 468:127–139. doi:10.​1007/​s00428-015-1864-y CrossRefPubMed
8.
Zurück zum Zitat Adam P, Baumann R, Schmidt J, Bettio S, Weisel K, Bonzheim I, Fend F, Quintanilla-Martinez L (2013) The BCL2 E17 and SP66 antibodies discriminate 2 immunophenotypically and genetically distinct subgroups of conventionally BCL2-“negative” grade 1/2 follicular lymphomas. Hum Pathol 44:1817–1826. doi:10.1016/j.humpath.2013.02.004 CrossRefPubMed Adam P, Baumann R, Schmidt J, Bettio S, Weisel K, Bonzheim I, Fend F, Quintanilla-Martinez L (2013) The BCL2 E17 and SP66 antibodies discriminate 2 immunophenotypically and genetically distinct subgroups of conventionally BCL2-“negative” grade 1/2 follicular lymphomas. Hum Pathol 44:1817–1826. doi:10.​1016/​j.​humpath.​2013.​02.​004 CrossRefPubMed
9.
Zurück zum Zitat Schraders M, de Jong D, Kluin P, Groenen P, van Krieken H (2005) Lack of Bcl-2 expression in follicular lymphoma may be caused by mutations in the BCL2 gene or by absence of the t(14;18) translocation. J Pathol 205:329–335. doi:10.1002/path.1689 CrossRefPubMed Schraders M, de Jong D, Kluin P, Groenen P, van Krieken H (2005) Lack of Bcl-2 expression in follicular lymphoma may be caused by mutations in the BCL2 gene or by absence of the t(14;18) translocation. J Pathol 205:329–335. doi:10.​1002/​path.​1689 CrossRefPubMed
10.
Zurück zum Zitat Correia C, Schneider PA, Dai H, Dogan A, Maurer MJ, Church AK, Novak AJ, Feldman AL, Wu X, Ding H, Meng XW, Cerhan JR, Slager SL, Macon WR, Habermann TM, Karp JE, Gore SD, Kay NE, Jelinek DF, Witzig TE, Nowakowski GS, Kaufmann SH (2015) BCL2 mutations are associated with increased risk of transformation and shortened survival in follicular lymphoma. Blood 125:658–667. doi:10.1182/blood-2014-04-571786 CrossRefPubMedPubMedCentral Correia C, Schneider PA, Dai H, Dogan A, Maurer MJ, Church AK, Novak AJ, Feldman AL, Wu X, Ding H, Meng XW, Cerhan JR, Slager SL, Macon WR, Habermann TM, Karp JE, Gore SD, Kay NE, Jelinek DF, Witzig TE, Nowakowski GS, Kaufmann SH (2015) BCL2 mutations are associated with increased risk of transformation and shortened survival in follicular lymphoma. Blood 125:658–667. doi:10.​1182/​blood-2014-04-571786 CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Pastore A, Jurinovic V, Kridel R, Hoster E, Staiger AM, Szczepanowski M, Pott C, Kopp N, Murakami M, Horn H, Leich E, Moccia AA, Mottok A, Sunkavalli A, Van Hummelen P, Ducar M, Ennishi D, Shulha HP, Hother C, Connors JM, Sehn LH, Dreyling M, Neuberg D, Moller P, Feller AC, Hansmann ML, Stein H, Rosenwald A, Ott G, Klapper W, Unterhalt M, Hiddemann W, Gascoyne RD, Weinstock DM, Weigert O (2015) Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry. Lancet Oncol 16:1111–1122. doi:10.1016/S1470-2045(15)00169-2 CrossRefPubMed Pastore A, Jurinovic V, Kridel R, Hoster E, Staiger AM, Szczepanowski M, Pott C, Kopp N, Murakami M, Horn H, Leich E, Moccia AA, Mottok A, Sunkavalli A, Van Hummelen P, Ducar M, Ennishi D, Shulha HP, Hother C, Connors JM, Sehn LH, Dreyling M, Neuberg D, Moller P, Feller AC, Hansmann ML, Stein H, Rosenwald A, Ott G, Klapper W, Unterhalt M, Hiddemann W, Gascoyne RD, Weinstock DM, Weigert O (2015) Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry. Lancet Oncol 16:1111–1122. doi:10.​1016/​S1470-2045(15)00169-2 CrossRefPubMed
12.
Zurück zum Zitat Karube K, Martinez D, Royo C, Navarro A, Pinyol M, Cazorla M, Castillo P, Valera A, Carrio A, Costa D, Colomer D, Rosenwald A, Ott G, Esteban D, Gine E, Lopez-Guillermo A, Campo E (2014) Recurrent mutations of NOTCH genes in follicular lymphoma identify a distinctive subset of tumours. J Pathol 234:423–430. doi:10.1002/path.4428 CrossRefPubMed Karube K, Martinez D, Royo C, Navarro A, Pinyol M, Cazorla M, Castillo P, Valera A, Carrio A, Costa D, Colomer D, Rosenwald A, Ott G, Esteban D, Gine E, Lopez-Guillermo A, Campo E (2014) Recurrent mutations of NOTCH genes in follicular lymphoma identify a distinctive subset of tumours. J Pathol 234:423–430. doi:10.​1002/​path.​4428 CrossRefPubMed
13.
Zurück zum Zitat Kridel R, Mottok A, Farinha P, Ben-Neriah S, Ennishi D, Zheng Y, Chavez EA, Shulha HP, Tan K, Chan FC, Boyle M, Meissner B, Telenius A, Sehn LH, Marra MA, Shah SP, Steidl C, Connors JM, Scott DW, Gascoyne RD (2015) Cell of origin of transformed follicular lymphoma. Blood 126:2118–2127. doi:10.1182/blood-2015-06-649905 CrossRefPubMedPubMedCentral Kridel R, Mottok A, Farinha P, Ben-Neriah S, Ennishi D, Zheng Y, Chavez EA, Shulha HP, Tan K, Chan FC, Boyle M, Meissner B, Telenius A, Sehn LH, Marra MA, Shah SP, Steidl C, Connors JM, Scott DW, Gascoyne RD (2015) Cell of origin of transformed follicular lymphoma. Blood 126:2118–2127. doi:10.​1182/​blood-2015-06-649905 CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, Muller-Hermelink HK, Campo E, Braziel RM, Jaffe ES, Pan Z, Farinha P, Smith LM, Falini B, Banham AH, Rosenwald A, Staudt LM, Connors JM, Armitage JO, Chan WC (2004) Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103:275–282. doi:10.1182/blood-2003-05-1545 CrossRefPubMed Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, Muller-Hermelink HK, Campo E, Braziel RM, Jaffe ES, Pan Z, Farinha P, Smith LM, Falini B, Banham AH, Rosenwald A, Staudt LM, Connors JM, Armitage JO, Chan WC (2004) Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103:275–282. doi:10.​1182/​blood-2003-05-1545 CrossRefPubMed
16.
Zurück zum Zitat Swerdlow S, Campo E, Harris NL, Jaffe ES, Pileri S, Stein H, Thiele J, Vardiman J (2008) WHO classification of tumours of haematopoietic and lymphoid tissues. IARC Press, Lyon Swerdlow S, Campo E, Harris NL, Jaffe ES, Pileri S, Stein H, Thiele J, Vardiman J (2008) WHO classification of tumours of haematopoietic and lymphoid tissues. IARC Press, Lyon
17.
Zurück zum Zitat Swerdlow SH, Kuzu I, Dogan A, Dirnhofer S, Chan JK, Sander B, Ott G, Xerri L, Quintanilla-Martinez L, Campo E (2016) The many faces of small B cell lymphomas with plasmacytic differentiation and the contribution of MYD88 testing. Virchows Arch 468:259–275. doi:10.1007/s00428-015-1858-9 CrossRefPubMed Swerdlow SH, Kuzu I, Dogan A, Dirnhofer S, Chan JK, Sander B, Ott G, Xerri L, Quintanilla-Martinez L, Campo E (2016) The many faces of small B cell lymphomas with plasmacytic differentiation and the contribution of MYD88 testing. Virchows Arch 468:259–275. doi:10.​1007/​s00428-015-1858-9 CrossRefPubMed
18.
Zurück zum Zitat Schmidt J, Federmann B, Schindler N, Steinhilber J, Bonzheim I, Fend F, Quintanilla-Martinez L (2015) MYD88 L265P and CXCR4 mutations in lymphoplasmacytic lymphoma identify cases with high disease activity. Br J Haematol 169:795–803. doi:10.1111/bjh.13361 CrossRefPubMed Schmidt J, Federmann B, Schindler N, Steinhilber J, Bonzheim I, Fend F, Quintanilla-Martinez L (2015) MYD88 L265P and CXCR4 mutations in lymphoplasmacytic lymphoma identify cases with high disease activity. Br J Haematol 169:795–803. doi:10.​1111/​bjh.​13361 CrossRefPubMed
19.
Zurück zum Zitat Treon SP, Cao Y, Xu L, Yang G, Liu X, Hunter ZR (2014) Somatic mutations in MYD88 and CXCR4 are determinants of clinical presentation and overall survival in Waldenstrom macroglobulinemia. Blood 123:2791–2796. doi:10.1182/blood-2014-01-550905 CrossRefPubMed Treon SP, Cao Y, Xu L, Yang G, Liu X, Hunter ZR (2014) Somatic mutations in MYD88 and CXCR4 are determinants of clinical presentation and overall survival in Waldenstrom macroglobulinemia. Blood 123:2791–2796. doi:10.​1182/​blood-2014-01-550905 CrossRefPubMed
22.
Zurück zum Zitat Minnema MC, Kimby E, D’Sa S, Fornecker LM, Poulain S, Snijders TJ, Kastritis E, Kremer S, Fitsiori A, Simon L, Davi F, Lunn M, Castillo JJ, Patterson CJ, Le Garff-Tavernier M, Costopoulos M, Leblond V, Kersten MJ, Dimopoulos MA, Treon SP (2017) Guideline for the diagnosis, treatment and response criteria for Bing-Neel syndrome. Haematologica 102:43–51. doi:10.3324/haematol.2016.147728 CrossRefPubMedPubMedCentral Minnema MC, Kimby E, D’Sa S, Fornecker LM, Poulain S, Snijders TJ, Kastritis E, Kremer S, Fitsiori A, Simon L, Davi F, Lunn M, Castillo JJ, Patterson CJ, Le Garff-Tavernier M, Costopoulos M, Leblond V, Kersten MJ, Dimopoulos MA, Treon SP (2017) Guideline for the diagnosis, treatment and response criteria for Bing-Neel syndrome. Haematologica 102:43–51. doi:10.​3324/​haematol.​2016.​147728 CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Castillo JJ, Gustine J, Meid K, Dubeau T, Hunter ZR, Treon SP (2016) Histological transformation to diffuse large B-cell lymphoma in patients with Waldenstrom macroglobulinemia. Am J Hematol 91:1032–1035. doi:10.1002/ajh.24477 CrossRefPubMed Castillo JJ, Gustine J, Meid K, Dubeau T, Hunter ZR, Treon SP (2016) Histological transformation to diffuse large B-cell lymphoma in patients with Waldenstrom macroglobulinemia. Am J Hematol 91:1032–1035. doi:10.​1002/​ajh.​24477 CrossRefPubMed
24.
Zurück zum Zitat Lin P, Mansoor A, Bueso-Ramos C, Hao S, Lai R, Medeiros LJ (2003) Diffuse large B-cell lymphoma occurring in patients with lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia. Clinicopathologic features of 12 cases. Am J Clin Pathol 120:246–253. doi:10.1309/r01v-xg46-mfcd-vnhl CrossRefPubMed Lin P, Mansoor A, Bueso-Ramos C, Hao S, Lai R, Medeiros LJ (2003) Diffuse large B-cell lymphoma occurring in patients with lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia. Clinicopathologic features of 12 cases. Am J Clin Pathol 120:246–253. doi:10.​1309/​r01v-xg46-mfcd-vnhl CrossRefPubMed
25.
26.
Zurück zum Zitat Falchi L, Keating MJ, Marom EM, Truong MT, Schlette EJ, Sargent RL, Trinh L, Wang X, Smith SC, Jain N, Estrov Z, O’Brien S, Wierda WG, Lerner S, Ferrajoli A (2014) Correlation between FDG/PET, histology, characteristics, and survival in 332 patients with chronic lymphoid leukemia. Blood 123:2783–2790. doi:10.1182/blood-2013-11-536169 CrossRefPubMedPubMedCentral Falchi L, Keating MJ, Marom EM, Truong MT, Schlette EJ, Sargent RL, Trinh L, Wang X, Smith SC, Jain N, Estrov Z, O’Brien S, Wierda WG, Lerner S, Ferrajoli A (2014) Correlation between FDG/PET, histology, characteristics, and survival in 332 patients with chronic lymphoid leukemia. Blood 123:2783–2790. doi:10.​1182/​blood-2013-11-536169 CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Gine E, Martinez A, Villamor N, Lopez-Guillermo A, Camos M, Martinez D, Esteve J, Calvo X, Muntanola A, Abrisqueta P, Rozman M, Rozman C, Bosch F, Campo E, Montserrat E (2010) Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia (“accelerated” chronic lymphocytic leukemia) with aggressive clinical behavior. Haematologica 95:1526–1533. doi:10.3324/haematol.2010.022277 CrossRefPubMedPubMedCentral Gine E, Martinez A, Villamor N, Lopez-Guillermo A, Camos M, Martinez D, Esteve J, Calvo X, Muntanola A, Abrisqueta P, Rozman M, Rozman C, Bosch F, Campo E, Montserrat E (2010) Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia (“accelerated” chronic lymphocytic leukemia) with aggressive clinical behavior. Haematologica 95:1526–1533. doi:10.​3324/​haematol.​2010.​022277 CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Oscier D, Else M, Matutes E, Morilla R, Strefford JC, Catovsky D (2016) The morphology of CLL revisited: the clinical significance of prolymphocytes and correlations with prognostic/molecular markers in the LRF CLL4 trial. Br J Haematol 174:767–775. doi:10.1111/bjh.14132 CrossRefPubMedPubMedCentral Oscier D, Else M, Matutes E, Morilla R, Strefford JC, Catovsky D (2016) The morphology of CLL revisited: the clinical significance of prolymphocytes and correlations with prognostic/molecular markers in the LRF CLL4 trial. Br J Haematol 174:767–775. doi:10.​1111/​bjh.​14132 CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Agbay RL, Jain N, Loghavi S, Medeiros LJ, Khoury JD (2016) Histologic transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma. Am J Hematol 91:1036–1043. doi:10.1002/ajh.24473 CrossRefPubMed Agbay RL, Jain N, Loghavi S, Medeiros LJ, Khoury JD (2016) Histologic transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma. Am J Hematol 91:1036–1043. doi:10.​1002/​ajh.​24473 CrossRefPubMed
32.
Zurück zum Zitat Parikh SA, Habermann TM, Chaffee KG, Call TG, Ding W, Leis JF, Macon WR, Schwager SM, Ristow KM, Porrata LF, Kay NE, Slager SL, Shanafelt TD (2015) Hodgkin transformation of chronic lymphocytic leukemia: incidence, outcomes, and comparison to de novo Hodgkin lymphoma. Am J Hematol 90:334–338. doi:10.1002/ajh.23939 CrossRefPubMedPubMedCentral Parikh SA, Habermann TM, Chaffee KG, Call TG, Ding W, Leis JF, Macon WR, Schwager SM, Ristow KM, Porrata LF, Kay NE, Slager SL, Shanafelt TD (2015) Hodgkin transformation of chronic lymphocytic leukemia: incidence, outcomes, and comparison to de novo Hodgkin lymphoma. Am J Hematol 90:334–338. doi:10.​1002/​ajh.​23939 CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat de Leval L, Vivario M, De Prijck B, Zhou Y, Boniver J, Harris NL, Isaacson P, Du MQ (2004) Distinct clonal origin in two cases of Hodgkin’s lymphoma variant of Richter’s syndrome associated with EBV infection. Am J Surg Pathol 28:679–686CrossRefPubMed de Leval L, Vivario M, De Prijck B, Zhou Y, Boniver J, Harris NL, Isaacson P, Du MQ (2004) Distinct clonal origin in two cases of Hodgkin’s lymphoma variant of Richter’s syndrome associated with EBV infection. Am J Surg Pathol 28:679–686CrossRefPubMed
34.
Zurück zum Zitat Mao Z, Quintanilla-Martinez L, Raffeld M, Richter M, Krugmann J, Burek C, Hartmann E, Rudiger T, Jaffe ES, Muller-Hermelink HK, Ott G, Fend F, Rosenwald A (2007) IgVH mutational status and clonality analysis of Richter’s transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution. Am J Surg Pathol 31:1605–1614. doi:10.1097/PAS.0b013e31804bdaf8 CrossRefPubMed Mao Z, Quintanilla-Martinez L, Raffeld M, Richter M, Krugmann J, Burek C, Hartmann E, Rudiger T, Jaffe ES, Muller-Hermelink HK, Ott G, Fend F, Rosenwald A (2007) IgVH mutational status and clonality analysis of Richter’s transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution. Am J Surg Pathol 31:1605–1614. doi:10.​1097/​PAS.​0b013e31804bdaf8​ CrossRefPubMed
35.
Zurück zum Zitat Rossi D, Spina V, Deambrogi C, Rasi S, Laurenti L, Stamatopoulos K, Arcaini L, Lucioni M, Rocque GB, Xu-Monette ZY, Visco C, Chang J, Chigrinova E, Forconi F, Marasca R, Besson C, Papadaki T, Paulli M, Larocca LM, Pileri SA, Gattei V, Bertoni F, Foa R, Young KH, Gaidano G (2011) The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation. Blood 117:3391–3401. doi:10.1182/blood-2010-09-302174 CrossRefPubMed Rossi D, Spina V, Deambrogi C, Rasi S, Laurenti L, Stamatopoulos K, Arcaini L, Lucioni M, Rocque GB, Xu-Monette ZY, Visco C, Chang J, Chigrinova E, Forconi F, Marasca R, Besson C, Papadaki T, Paulli M, Larocca LM, Pileri SA, Gattei V, Bertoni F, Foa R, Young KH, Gaidano G (2011) The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation. Blood 117:3391–3401. doi:10.​1182/​blood-2010-09-302174 CrossRefPubMed
36.
Zurück zum Zitat Schlette E, Bueso-Ramos C, Giles F, Glassman A, Hayes K, Medeiros LJ (2001) Mature B-cell leukemias with more than 55% prolymphocytes. A heterogeneous group that includes an unusual variant of mantle cell lymphoma. Am J Clin Pathol 115:571–581. doi:10.1309/PPK0-TJUK-1UAR-3194 CrossRefPubMed Schlette E, Bueso-Ramos C, Giles F, Glassman A, Hayes K, Medeiros LJ (2001) Mature B-cell leukemias with more than 55% prolymphocytes. A heterogeneous group that includes an unusual variant of mantle cell lymphoma. Am J Clin Pathol 115:571–581. doi:10.​1309/​PPK0-TJUK-1UAR-3194 CrossRefPubMed
37.
Zurück zum Zitat Flatley E, Chen AI, Zhao X, Jaffe ES, Dunlap JB, Pittaluga S, Abdullah S, Olson SB, Spurgeon SE, Fan G (2014) Aberrations of MYC are a common event in B-cell prolymphocytic leukemia. Am J Clin Pathol 142:347–354. doi:10.1309/AJCPUBHM8U7ZFLOB CrossRefPubMed Flatley E, Chen AI, Zhao X, Jaffe ES, Dunlap JB, Pittaluga S, Abdullah S, Olson SB, Spurgeon SE, Fan G (2014) Aberrations of MYC are a common event in B-cell prolymphocytic leukemia. Am J Clin Pathol 142:347–354. doi:10.​1309/​AJCPUBHM8U7ZFLOB​ CrossRefPubMed
38.
Zurück zum Zitat Kanellis G, Garcia-Alonso L, Camacho FI, Garcia JF, Mollejo M, Montes-Moreno S, Garcia-Vela JA, Piris MA (2011) Hairy cell leukemia, blastic type: description of spleen morphology and immunophenotype of a distinctive case. Leuk Lymphoma 52:1589–1592. doi:10.3109/10428194.2011.575488 CrossRefPubMed Kanellis G, Garcia-Alonso L, Camacho FI, Garcia JF, Mollejo M, Montes-Moreno S, Garcia-Vela JA, Piris MA (2011) Hairy cell leukemia, blastic type: description of spleen morphology and immunophenotype of a distinctive case. Leuk Lymphoma 52:1589–1592. doi:10.​3109/​10428194.​2011.​575488 CrossRefPubMed
40.
43.
Zurück zum Zitat Aguilar C, Beltran B, Quinones P, Carbajal T, Vilcapaza J, Yabar A, Segura P, Quintanilla-Martinez L, Miranda RN, Castillo JJ (2015) Large B-cell lymphoma arising in cardiac myxoma or intracardiac fibrinous mass: a localized lymphoma usually associated with Epstein-Barr virus? Cardiovasc Pathol 24:60–64. doi:10.1016/j.carpath.2014.08.007 CrossRefPubMed Aguilar C, Beltran B, Quinones P, Carbajal T, Vilcapaza J, Yabar A, Segura P, Quintanilla-Martinez L, Miranda RN, Castillo JJ (2015) Large B-cell lymphoma arising in cardiac myxoma or intracardiac fibrinous mass: a localized lymphoma usually associated with Epstein-Barr virus? Cardiovasc Pathol 24:60–64. doi:10.​1016/​j.​carpath.​2014.​08.​007 CrossRefPubMed
45.
Zurück zum Zitat Cheuk W, Chan AC, Chan JK, Lau GT, Chan VN, Yiu HH (2005) Metallic implant-associated lymphoma: a distinct subgroup of large B-cell lymphoma related to pyothorax-associated lymphoma? Am J Surg Pathol 29:832–836CrossRefPubMed Cheuk W, Chan AC, Chan JK, Lau GT, Chan VN, Yiu HH (2005) Metallic implant-associated lymphoma: a distinct subgroup of large B-cell lymphoma related to pyothorax-associated lymphoma? Am J Surg Pathol 29:832–836CrossRefPubMed
47.
Zurück zum Zitat Boyer DF, McKelvie PA, de Leval L, Edlefsen KL, Ko YH, Aberman ZA, Kovach AE, Masih A, Nishino HT, Weiss LM, Meeker AK, Nardi V, Palisoc M, Shao L, Pittaluga S, Ferry JA, Harris NL, Sohani AR (2017) Fibrin-associated EBV-positive large B-cell lymphoma: an indolent neoplasm with features distinct from diffuse large B-cell lymphoma associated with chronic inflammation. Am J Surg Pathol 41:299–312. doi:10.1097/PAS.0000000000000775 CrossRefPubMed Boyer DF, McKelvie PA, de Leval L, Edlefsen KL, Ko YH, Aberman ZA, Kovach AE, Masih A, Nishino HT, Weiss LM, Meeker AK, Nardi V, Palisoc M, Shao L, Pittaluga S, Ferry JA, Harris NL, Sohani AR (2017) Fibrin-associated EBV-positive large B-cell lymphoma: an indolent neoplasm with features distinct from diffuse large B-cell lymphoma associated with chronic inflammation. Am J Surg Pathol 41:299–312. doi:10.​1097/​PAS.​0000000000000775​ CrossRefPubMed
49.
Zurück zum Zitat Ichinohasama R, Miura I, Kobayashi N, Saitoh Y, DeCoteau JF, Saiki Y, Mori S, Kadin ME, Ooya K (1998) Herpes virus type 8-negative primary effusion lymphoma associated with PAX-5 gene rearrangement and hepatitis C virus: a case report and review of the literature. Am J Surg Pathol 22:1528–1537CrossRefPubMed Ichinohasama R, Miura I, Kobayashi N, Saitoh Y, DeCoteau JF, Saiki Y, Mori S, Kadin ME, Ooya K (1998) Herpes virus type 8-negative primary effusion lymphoma associated with PAX-5 gene rearrangement and hepatitis C virus: a case report and review of the literature. Am J Surg Pathol 22:1528–1537CrossRefPubMed
50.
Zurück zum Zitat Wu W, Youm W, Rezk SA, Zhao X (2013) Human herpesvirus 8-unrelated primary effusion lymphoma-like lymphoma: report of a rare case and review of 54 cases in the literature. Am J Clin Pathol 140:258–273. doi:10.1309/AJCPHZ3CHO4HUWET CrossRefPubMed Wu W, Youm W, Rezk SA, Zhao X (2013) Human herpesvirus 8-unrelated primary effusion lymphoma-like lymphoma: report of a rare case and review of 54 cases in the literature. Am J Clin Pathol 140:258–273. doi:10.​1309/​AJCPHZ3CHO4HUWET​ CrossRefPubMed
52.
Zurück zum Zitat Tanaka S, Katano H, Tsukamoto K, Jin M, Oikawa S, Nishihara H, Sawa H, Sawada K, Shimizu M, Sata T, Fujioka Y, Nagashima K (2001) HHV8-negative primary effusion lymphoma of the peritoneal cavity presenting with a distinct immunohistochemical phenotype. Pathol Int 51:293–300CrossRefPubMed Tanaka S, Katano H, Tsukamoto K, Jin M, Oikawa S, Nishihara H, Sawa H, Sawada K, Shimizu M, Sata T, Fujioka Y, Nagashima K (2001) HHV8-negative primary effusion lymphoma of the peritoneal cavity presenting with a distinct immunohistochemical phenotype. Pathol Int 51:293–300CrossRefPubMed
53.
Zurück zum Zitat Grisariu S, Avni B, Batchelor TT, van den Bent MJ, Bokstein F, Schiff D, Kuittinen O, Chamberlain MC, Roth P, Nemets A, Shalom E, Ben-Yehuda D, Siegal T, International Primary CNSLCG (2010) Neurolymphomatosis: an international primary CNS lymphoma collaborative group report. Blood 115:5005–5011. doi:10.1182/blood-2009-12-258210 CrossRefPubMedPubMedCentral Grisariu S, Avni B, Batchelor TT, van den Bent MJ, Bokstein F, Schiff D, Kuittinen O, Chamberlain MC, Roth P, Nemets A, Shalom E, Ben-Yehuda D, Siegal T, International Primary CNSLCG (2010) Neurolymphomatosis: an international primary CNS lymphoma collaborative group report. Blood 115:5005–5011. doi:10.​1182/​blood-2009-12-258210 CrossRefPubMedPubMedCentral
54.
Zurück zum Zitat Del Grande A, Sabatelli M, Luigetti M, Conte A, Granata G, Rufini V, Del Ciello A, Gaudino S, Fernandez E, Hohaus S, Coli A, Lauriola L (2014) Primary multifocal lymphoma of peripheral nervous system: case report and review of the literature. Muscle Nerve 50:1016–1022. doi:10.1002/mus.24354 CrossRefPubMed Del Grande A, Sabatelli M, Luigetti M, Conte A, Granata G, Rufini V, Del Ciello A, Gaudino S, Fernandez E, Hohaus S, Coli A, Lauriola L (2014) Primary multifocal lymphoma of peripheral nervous system: case report and review of the literature. Muscle Nerve 50:1016–1022. doi:10.​1002/​mus.​24354 CrossRefPubMed
58.
Zurück zum Zitat Misdraji J, Ino Y, Louis DN, Rosenberg AE, Chiocca EA, Harris NL (2000) Primary lymphoma of peripheral nerve: report of four cases. Am J Surg Pathol 24:1257–1265CrossRefPubMed Misdraji J, Ino Y, Louis DN, Rosenberg AE, Chiocca EA, Harris NL (2000) Primary lymphoma of peripheral nerve: report of four cases. Am J Surg Pathol 24:1257–1265CrossRefPubMed
59.
Zurück zum Zitat Quinones-Hinojosa A, Friedlander RM, Boyer PJ, Batchelor TT, Chiocca EA (2000) Solitary sciatic nerve lymphoma as an initial manifestation of diffuse neurolymphomatosis. Case Ref Rev Lit J Neurosurg 92:165–169. doi:10.3171/jns.2000.92.1.0165 Quinones-Hinojosa A, Friedlander RM, Boyer PJ, Batchelor TT, Chiocca EA (2000) Solitary sciatic nerve lymphoma as an initial manifestation of diffuse neurolymphomatosis. Case Ref Rev Lit J Neurosurg 92:165–169. doi:10.​3171/​jns.​2000.​92.​1.​0165
Metadaten
Titel
B-cell lymphomas with discordance between pathological features and clinical behavior
verfasst von
Laurence de Leval
Christiane Copie-Bergman
Andreas Rosenwald
Lisa Rimsza
Stefania Pittaluga
Bettina Bisig
Stefan Dirnhofer
Fabio Facchetti
Stefano Pileri
Falko Fend
Andrew Wotherspoon
Publikationsdatum
01.06.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Virchows Archiv / Ausgabe 4/2017
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-017-2152-9

Weitere Artikel der Ausgabe 4/2017

Virchows Archiv 4/2017 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …